Intellectual property (IP) is crucial in biotech; owning IP is necessary to justify the investment in development and clinical studies.

It's crucial for a company to own any created IP from the start, which can be established with a simple IP assignment agreement for a nominal amount.

Keep your startup organized by following standard practices, understanding equity ownership, and ensuring all IP is assigned to the company.

In academia, most intellectual property is owned by universities, which complicates the process for researchers wanting to commercialize their discoveries.

The ownership of scientific results is crucial in research, and figuring out who owns the results and intellectual property can be very challenging.

When hiring, companies will likely want to own the intellectual property of the agents that employees bring with them.

It's vital for founders to stay informed about the financial and legal aspects of their startup, as misunderstandings can lead to significant issues down the line.

From day one, we filed patents to protect our intellectual property, especially while competing against giants like Microsoft and Intel, although the patents didn't provide much help in the long run.

Filing provisional patents within 12 months of announcing a product is crucial to protect intellectual property. This step is often overlooked but can save significant legal trouble later.